Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM    DSM   NL0000009827

ROYAL DSM (DSM)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Royal DSM : DSM hosts successful 2017 Innovation Partnering Conference with eight promising food & biotech start-ups in Delft

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/06/2017 | 10:10am CEST

Speaking at the opening of the conference, Patrick Niels, President of DSM Food Specialties, emphasized the importance of venturing and open innovation in the modern business world: 'At DSM Food Specialties, we aim to enable better food for everyone, helping to make people's diets healthier, tastier, and more sustainable. Encouraging open innovation like this is an important part of our approach; there are so many great ideas and courageous start-ups out there, and this is one way for us to tap into them, hopefully to the benefit of our customers, our business - and of course for the entrepreneurs themselves.'

Eight finalists

An expert panel from DSM and Nutrition Capital Network evaluated a long-list of entrepreneurs and innovators who applied to attend Connecting Bright Innovations 2017, ultimately inviting eight companies to pitch in Delft.

The finalists were: 3f Bio (UK), Alderys (France), Biosyntia (Denmark), Chinova Bioworks (Canada), Kiverdi (US), Pectcof (Netherlands), Swiss DeCode (Switzerland) and Zymtronix (US).

High standard

Krijn Rietveld, Senior Vice President Partnering for Innovation at DSM, heads the Connecting Bright Innovations 2017 panel: 'We were impressed by the high standard of the pitches we heard during the conference, so congratulations to all who took part. It's inspiring to see such passion, drive and energy. The technologies and business cases on show were very interesting, and I am sure that there are a number with whom we will be able to take our relationship further, to see how DSM can help scale up their promising platforms to realize their full commercial potential.'

Delft, world-leading location for biotech

Connecting Bright Innovations 2017 was held at the Rosalind Franklin Biotechnology Center on the DSM site in Delft. The center's location at the heart of the Biotech Campus Delft allows DSM to rapidly develop and scale up biotechnology solutions for promising new ingredients for customer validation and commercial roll-out. The Biotech Campus Delft, an initiative of DSM Delft, Delft University of Technology, the City of Delft and the Province of South Holland, builds on the location's existing competences and internationally recognized position as a world leader in biotechnology development. It brings together fundamental science and R&D, applications expertise, piloting and scale-up facilities as well commercial and market insights and relationships on one location, being also the global headquarters of DSM Food Specialties.

Koninklijke DSM NV published this content on 06 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 October 2017 08:09:04 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ROYAL DSM
07/12ROYAL DSM : DSM to introduce new generation sweetener AVANSYA™ Reb M at IF..
PU
07/10ROYAL DSM : DSM introduces PreventASe® XR to extend use of enzymatic acrylamide-..
PU
07/06CONCENTRATED RECOVERY : DSM’s Fruitflow® to power athletes in grueling Tou..
PU
07/05MOLECULAR MEDICINE : Reports on Molecular Medicine from Chinese Academy of Agric..
AQ
07/05ROYAL DSM : DSM launches new Coating Resins website to provide insight into perf..
PU
07/02ROYAL DSM : DSM becomes largest shareholder in Mixfit Inc. to enter B2C personal..
PU
06/29ROYAL DSM : DSM informs market on the announced sale of DSM Sinochem Pharmaceuti..
PU
06/28ROYAL DSM : DSM introduces BakeZyme® AAA baking enzyme for cost-effective produc..
PU
06/20Dutch DSM hoards $3.5 billion to fuel nutrition growth
RE
06/20ROYAL DSM : DSM strategy update
PU
More news
News from SeekingAlpha
06/18INTERNATIONAL FLAVORS & FRAGRANCES : That Taste In Your Mouth - Bitter Or Sweet? 
05/13Royal DSM NV ADR's (RDSMY) CFO Geraldine Matchett on Q1 2018 Results - Earnin.. 
05/08Koninklijke DSM NV 2018 Q1 - Results - Earnings Call Slides 
05/08Royal DSM reports Q1 results 
02/28ROYAL DSM : A Very Sustainable Company And Good For Your Wallet As Well 
Financials (€)
Sales 2018 9 339 M
EBIT 2018 1 319 M
Net income 2018 1 018 M
Debt 2018 683 M
Yield 2018 2,34%
P/E ratio 2018 15,88
P/E ratio 2019 18,52
EV / Sales 2018 1,82x
EV / Sales 2019 1,77x
Capitalization 16 275 M
Chart ROYAL DSM
Duration : Period :
Royal DSM Technical Analysis Chart | DSM | NL0000009827 | 4-Traders
Technical analysis trends ROYAL DSM
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 98,7 €
Spread / Average Target 8,6%
EPS Revisions
Managers
NameTitle
Feike Sijbesma CEO & Chairman-Management Board
Robert John Routs Chairman-Supervisory Board
Géraldine Matchett Chief Financial Officer
Robert M. van Leen Head-Innovation, Research & Development
Pauline F. M. van der Meer Mohr Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM14.10%18 858
DOWDUPONT-5.84%154 007
BASF-8.09%88 799
GROUPE BRUXELLES LAMBERT1.37%17 069
EVONIK INDUSTRIES1.05%16 914
MITSUBISHI CHEMICAL HOLDINGS CORP.-23.96%12 706